RxDoctor Payments Data

Arun Rai, MD

Urology · Houston, TXNPI 1508278995

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $905,571 of the $920,349 with a category attached, or 98.4%. Histosonics, Inc. accounts for 96.4% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $889,987, more than ten times the $50 reported in 2019. Among urology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$920,349in general payments, 2019–2025

Across 67 payments — averaging $13,737 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Histosonics, Inc.$888K
  • Activ Surgical, Inc.$21K
  • Intuitive Surgical$6K
  • Novo Nordisk$2K
  • Stryker$1K
  • Boston Scientific$864
  • plus $1K from 7 others
$86,492in research payments, 2019–2025

Across 1 payment — averaging $86,492 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Histosonics, Inc.$86K

What the payments were for

  • Consulting fees$905,57198%
  • Travel & lodging$7,3711%
  • Food & beverage$3,4070%
  • Education$4,0000%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$920,349 in reported general payments places this provider in the 95th percentile of 878 urology providers in Texas.

See all urology providers in Texas

Medicare billing

Part B allowed, 2024
$181,053
Medicare patients
425
Services billed
1,220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Potassium Citrate ErPotassium Citrate165$18,429
MyrbetriqMirabegron18$15,812
Solifenacin Succinate88$6,514
Tamsulosin Hcl294$4,765
Finasteride141$1,789
Estradiol18$960
Alfuzosin Hcl ErAlfuzosin Hcl14$957
Oxybutynin Chloride32$647
Oxybutynin Chloride ErOxybutynin Chloride34$603
Chlorthalidone19$291
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav32$190
Allopurinol15$143
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim22$124
Ciprofloxacin Hcl16$106
Hydrochlorothiazide12$58

Paid to pharmacies, not to this prescriber.

Other urology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →